Yong-gang Fan

Key Laboratory Of Medical Cell Biology Of Ministry Of Education, Key Laboratory Of Major Chronic Diseases Of Nervous System Of Liaoning Province
Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

The cGAS-STING pathway at the crossroads of neuroimmunology: bridging innate immunity to aging and neurodegeneration.

The cGAS-STING pathway at the crossroads of neuroimmunology: bridging innate immunity to aging and neurodegeneration.

Journal: Biomarker research

Published: December 12, 2025

AS1842856 Reduces β-Amyloid Burden via Inhibiting PLA2G4A-Mediated Lysosomal Dysfunction in APP/PS1 Mice.

AS1842856 Reduces β-Amyloid Burden via Inhibiting PLA2G4A-Mediated Lysosomal Dysfunction in APP/PS1 Mice.

Journal: CNS neuroscience & therapeutics

Published: November 20, 2025

Graphdiyne biomaterials: from characterization to properties and applications.

Graphdiyne biomaterials: from characterization to properties and applications.

Journal: Journal of nanobiotechnology

Published: October 23, 2024

Osmundacetone ameliorates Alzheimer's-like pathologies by inhibiting β-amyloid fibrillation, oxidative damage and neuroinflammation in APP/PS1 transgenic mice.

Osmundacetone ameliorates Alzheimer's-like pathologies by inhibiting β-amyloid fibrillation, oxidative damage and neuroinflammation in APP/PS1 transgenic mice.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 04, 2024

Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP/PS1 transgenic mice.

Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP/PS1 transgenic mice.

Journal: Pharmacological research

Published: May 23, 2024

Identification of AS1842856 as a novel small-molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis.

Identification of AS1842856 as a novel small-molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis.

Journal: Aging cell

Published: April 14, 2024

Potential Application Prospects of Biomolecule-Modified Two-Dimensional Chiral Nanomaterials in Biomedicine.

Potential Application Prospects of Biomolecule-Modified Two-Dimensional Chiral Nanomaterials in Biomedicine.

Journal: ACS biomaterials science & engineering

Published: March 20, 2024

From zinc homeostasis to disease progression: Unveiling the neurodegenerative puzzle.

From zinc homeostasis to disease progression: Unveiling the neurodegenerative puzzle.

Journal: Pharmacological research

Published: October 07, 2023

Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma.

Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 31, 2022

Astrocyte-derived lactoferrin reduces β-amyloid burden by promoting the interaction between p38 kinase and PP2A phosphatase in male APP/PS1 transgenic mice.

Astrocyte-derived lactoferrin reduces β-amyloid burden by promoting the interaction between p38 kinase and PP2A phosphatase in male APP/PS1 transgenic mice.

Journal: British journal of pharmacology

Published: November 25, 2022

The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.

The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.

Journal: Bioorganic chemistry

Published: September 01, 2022

Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues.

Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues.

Journal: Current neuropharmacology

Published: April 12, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026